Adverse reaction to Coartem (artemether/lumefantrine) resulting in oculogyric crisis

BACKGROUND: Artemether/lumefantrine (AL), sold under the brand name Coartem, is the most common artemisinin-based combination therapy for the treatment of malaria. Drug-induced oculogyric crisis is a neurological disorder characterized by frequent upward deviations of the eye. In the literature, no...

Descripción completa

Detalles Bibliográficos
Autores principales: Amponsah, Emmanuel Kofi, Sodnom-Ish, Buyanbileg, Anyetei-Anum, Aaron Sowah, Frimpong, Paul, Kim, Soung Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8134644/
https://www.ncbi.nlm.nih.gov/pubmed/34013443
http://dx.doi.org/10.1186/s40902-021-00300-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8134644/
https://www.ncbi.nlm.nih.gov/pubmed/34013443
http://dx.doi.org/10.1186/s40902-021-00300-y

Ejemplares similares